Financial indicators
Activism target signal
— PBR 0.55 & Debt-to-equity ratio 6.6%
Market cap
627 × 100M KRW
PBR
0.55
PER
5.7
ROE
10.65%
Dividend yield
-
Debt-to-equity ratio
6.6%
Share price history
Share price
Daily close
Latest close
-
-
5-year high
-
-
5-year low
-
-
Use the period buttons above to adjust the range.
Annual earnings Trend
Financial statements
Legacy summaries and estimates; may include data with unverified accounting scope.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 248 × 100M KRW | 282 × 100M KRW | 289 × 100M KRW |
| Operating profit | 77 × 100M KRW | 90 × 100M KRW | 93 × 100M KRW |
| Net income | 72 × 100M KRW | 84 × 100M KRW | 85 × 100M KRW |
| Operating margin | 30.90% | 31.79% | 32.30% |
| EPS | KRW 1,193 | KRW 1,402 | KRW 1,409 |
Property holdings
Property data is not available yet.
Articles of incorporation analysis
Articles of incorporation analysis is not available yet.
Executive compensation
Executive compensation data is not available yet.
Holders of 5% or more
| Holder | Holding ratio | Change in ownership | Reason for filing | Filing date |
|---|---|---|---|---|
| 한림제약 | 66.11% | +66.11% | 코스닥시장 상장에 따른 보고 | 2026-07-30 |
Auditors
Analysis date 2026.08.26 13:17
| Auditor | Type | Term start | Term end | Tenure | D-day |
|---|---|---|---|---|---|
| 천영진 | Audit committee member | - | 2028.08.27 | - | D-691 |
| 신호석 | Audit committee member | - | 2028.08.27 | - | D-691 |
| 김지선 | Audit committee member | - | 2029.03.30 | - | D-906 |
Executives
Executive data is not available yet.
DART disclosures
Loading disclosures…